Keynote Lectures – Invited Talks

Keynotes

 

 

Professor Nikolaos Robakis, Professor of Psychiatry, Neuroscience and experimental therapeutics. First A.P. Slaner Professor for Alzheimer disease research. Mount Sinai School of Medicine, NYU, USA, Title: Molecular neuropathology of Alzheimer dementia and therapeutic approachesProfessor

George Paxinos, AO DSc FASSA FAA NHMRC Australia Fellow, Neuroscience Research Australia, Barker St and Hospital Rd, Randwick, Sydney, Australia, Title: Brain, Behaviour and Evolution

Professor Vasilis Ntziachristos, Chair Institute for biological and medical imaging (ΙΒΜΙ) Technische Universität München, Germany, Title: Biomedical optics and optoacoustics as a model for scientific discovery and economic growth

Dr. Akihito Takashima, Department of Aging Neurobiology, National Center for Geriatrics and Gerontology, Japan, Title: Toxic tau aggregation in AD

Professor Benjamin Wolozin, Department of Pharmacology Boston University Alzheimer’s Disease Center, USA, Title: Stress granules and Neurodegeneration: A new paradigm for mechanisms of neurodegeneration

Professor Panteleimon Giannakopoulos, University of Lausanne, Department of Psychiatry University of Geneva School of Medicine, Switzerland, Title: Mental health in a global world: moving from illness to individual vulnerability

Dr. Efstathios Gonos, Director of Research IUBMB, National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Greece, Title: Proteasome activation delays ageing and minimize deficiencies underlying neurodegenerative diseases

Dr. Ioannis Haranas,VDG Research and Development in Electromagnetic Theory Applications, Department of Mathematics, East Carolina University, USA Title: Respiratory Particle Deposition Probability due to Sedimentation with Variable Gravity and Electrostatic Forces

Professor Dimitrios Fotiadis, Unit of Medical Technology and Intelligent Information Systems, University of Ioannina, Title: Sequence patterns mediating functions of disordered proteins

Professor Villringer Arno, Max Planck Institute for Human Cognitive and Brain Sciences, Germany, Title:The path from obesity and hypertension to dementia

Professor Constantin Bouras, University Hospitals, Geneva, Department of Psychiatry, Switzerland, Title: Individual severity of AD-type lesions, Aß oligomers and comorbidity in the brain aging

Professor Theodosia Vallianatou, Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Greece, Title: The impact of physicochemical and molecular properties in drug design. Navigation in the ‘drug-like’ chemical space,

Professor Costas Demetzos, Faculty of Pharmacy, National and Kapodistrian University of Athens, Title:  Advanced Drug Delivery nano Systems: perspectives and regulatory issues

Dr. Paraskevi Sakka, Neurologist-Psychiatrist, Director at Hygeia Hospital, Neurodegenerative Brain Conditions – Memory Clinic, Chairwoman at Athens Association of Alzheimer’s Disease, and Related Disorders, Greece, Title: Non-pharmacological treatments of dementia. The encouraging results of SOCIABLE